IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 372 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $219,428 | -81.1% | 5,348 | -82.6% | 0.00% | -83.3% |
| Q4 2022 | $1,159,879 | -83.5% | 30,709 | -83.8% | 0.01% | -85.0% |
| Q1 2022 | $7,021,000 | -13.5% | 189,556 | -29.0% | 0.04% | -9.1% |
| Q4 2021 | $8,120,000 | +80.3% | 266,845 | +181.2% | 0.04% | +18.9% |
| Q3 2020 | $4,503,000 | -31.4% | 94,905 | -7.0% | 0.04% | -79.6% |
| Q2 2019 | $6,560,000 | +1212.0% | 102,063 | +1557.9% | 0.18% | +1106.7% |
| Q1 2019 | $500,000 | -87.5% | 6,156 | -92.6% | 0.02% | -82.6% |
| Q4 2016 | $3,986,000 | – | 83,336 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
| DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
| Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
| WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
| PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
| Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
| Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
| Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
| PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |